The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the Americas

European Journal of Human Genetics

Volumn 19, Issue 12, 2011, Pages 1276-1280

  Rempel, Julia D ^a   Hawkins, Kim ^a   Lande, Erin ^a   Nickerson, Peter ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

ethnicity; KIR centromeric; KIR telomeric; pro inflammatory immunity

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ABORIGINE; ADULT; AGED; ARTICLE; ASIAN; CANADA; CAUCASIAN; CENTROMERE; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENOTYPE; HAPLOTYPE; HEALTH DISPARITY; HUMAN; IMMUNOPHENOTYPING; INDIGENOUS PEOPLE; MALE; PRIORITY JOURNAL; TELOMERE; WESTERN HEMISPHERE;

ADULT; AGED; CANADA; CENTROMERE; CONTINENTAL POPULATION GROUPS; DISEASE RESISTANCE; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; RECEPTORS, KIR; SELECTION, GENETIC; TELOMERE; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 81455131733     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.114     Document Type: Article

References (43)

1. Khakoo SI, Thio CL, Martin MP et al: HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305: 872-874.
2. Martin MP, Gao X, Lee JH et al: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31: 429-434.
3. Luszczek W, Manczak M, Cislo M et al: Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 2004; 65: 758-766.
4. Yen JH, Lin CH, Tsai WC et al: Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis. Scand J Rheumatol 2006; 35: 124-127.
5. Lopez-Vazquez A, Rodrigo L, Martinez-Borra J et al: Protective effect of the HLABw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 2005; 192: 162-165.
6. Martin AM, Kulski JK, Gaudieri S et al: Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. Gene 2004; 335: 121-131.
7. Li H, Pascal V, Martin MP, Carrington M, Anderson SK: Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008; 4: e1000254.
8. Yawata M, Yawata N, Abi-Rached L, Parham P: Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol 2002; 22: 463-482.
9. Kulkarni S, Martin MP, Carrington M: The Yin and Yang of HLA and KIR in human disease. Semin Immunol 2008; 20: 343-352.
10. Martin MP, Pascal V, Yeager M et al: A mutation in KIR3DS1 that results in truncation and lack of cell surface expression. Immunogenetics 2007; 59: 823-829.
11. Hsu KC, Chida S, Dupont B, Geraghty DE: The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190: 40-52.
12. Norman PJ, Abi-Rached L, Gendzekhadze K et al: Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res 2009; 19: 757-769.
13. Miller CL, Strathdee SA, Spittal PM et al: Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting. Harm Reduct J 2006; 3: 9-12.
14. Wu HX, Wu J, Wong T et al: Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004. Eur J Clin Microbiol Infect Dis 2007; 26: 167-174.
15. Minuk GY, Uhanova J: Viral hepatitis in the Canadian Inuit and First Nations populations. Can J Gastroenterol 2003; 17: 707-712.
16. Minuk GY, Zhang M, Wong SG et al: Viral hepatitis in a Canadian First Nations community. Can J Gastroenterol 2003; 17: 593-596.
17. Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW: Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 2007; 21: 447-451.
18. Dawood M, Smart G, Wood M, Wu HX, Paton S, Wu J: Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada: a public health laboratory study. Can J Microbiol 2006; 52: 999-1005.
19. Flores AC, Marcos CY, Paladino N et al: KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. Tissue Antigens 2007; 69: 568-576.
20. Gutierrez-Rodriguez ME, Sandoval-Ramirez L, Diaz-Flores M et al: KIR gene in ethnic and Mestizo populations from Mexico. Hum Immunol 2006; 67: 85-93.
21. Norman PJ, Carrington CV, Byng M et al: Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002; 3: 86-95.
22. Ashouri E, Farjadian S, Reed EF, Ghaderi A, Rajalingam R: KIR gene content diversity in four Iranian populations. Immunogenetics 2009; 61: 483-492.
23. Niokou D, Spyropoulou-Vlachou M, Darlamitsou A, Stavropoulos-Giokas C: Distribution of killer cell immunoglobulin-like receptors in the Greek population. Hum Immunol 2003; 64: 1167-1176.
24. Gendzekhadze K, Norman PJ, Abi-Rached L, Layrisse Z, Parham P: High KIR diversity in Amerindians is maintained using few gene-content haplotypes. Immunogenetics 2006; 58: 474-480.
25. Williams RC, Steinberg AG, Gershowitz H et al: GM allotypes in Native Americans: evidence for three distinct migrations across the Bering land bridge. Am J Phys Anthropol 1985; 66: 1-19.
26. Rickards O, Tartaglia M, Martinez-Labarga C, De Stefano GF: Genetic relationships among the Native American populations. Anthropol Anz 1994; 52: 193-213.
27. Jones DS: The persistence of American Indian health disparities. Am J Public Health 2006; 96: 2122-2134.
28. Bianchine PJ, Russo TA: The role of epidemic infectious diseases in the discovery of America. Allergy Proc 1992; 13: 225-232.
29. Sessa R, Palagiano C, Scifoni MG, di Pietro M, Del Piano M: The major epidemic infections: a gift from the Old World to the New? Panminerva Med 1999; 41: 78-84.
30. Houston CS, Houston S: The first smallpox epidemic on the Canadian Plains: in the fur-traders' words. Can J Infect Dis 2000; 11: 112-115.
31. Lorentzen AR, Karlsen TH, Olsson M et al: Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann Neurol 2009; 65: 658-666.
32. Jobim M, Chagastelles P, Salim PH et al: Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes. Hum Immunol 2010; 71: 799-803.
33. Miyashita R, Tsuchiya N, Yabe T et al: Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis Rheum 2006; 54: 992-997.
34. Shastry A, Sedimbi SK, Rajalingam R, Rumba I, Kanungo A, Sanjeevi CB: Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations. Ann NY Acad Sci 2008; 1150: 133-138.
35. Mauldin J, Cameron HD, Jeanotte D, Solomon G, Jarvis JN: Chronic arthritis in children and adolescents in two Indian health service user populations. BMC Musculoskelet Disord 2004; 5: 30.
36. Yoshida EM, Riley M, Arbour LT: Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia's Pacific Northwest. World J Gastroenterol 2006; 12: 3625-3627.
37. Ferucci ED, Templin DW, Lanier AP: Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature. Semin Arthritis Rheum 2005; 34: 662-667.
38. Peschken CA, Esdaile JM: Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 2000; 27: 1884-1891.
39. Paladino N, Flores AC, Marcos CY et al: Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 2007; 69 (Suppl 1): 109-111.
40. Montes-Cano MA, Caro-Oleas JL, Romero-Gomez M et al: HLA-C and KIR genes in hepatitis C virus infection. Hum Immunol 2005; 66: 1106-1109.
41. Aborsangaya K, Dembinski I, Khatkar S, Alphonse M, Nickerson P, Rempel JD: The impact of Aboriginal ethnicity on HCV Core induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. Hepatology 2007; 45: 623-630.
42. Rempel JD, Agborsangaya KB, Alphonse MP, Minuk GY: The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha. J Viral Hepat 2009; 16: 292-297.
43. Larcombe L, Rempel JD, Dembinski I, Tinckam K, Rigatto C, Nickerson P: Differential cytokine genotype frequencies among Canadian Aboriginal and Caucasian populations. Genes Immun 2005; 6: 140-144.